Clinical trial
Randomized Study Comparing CMF and Goserelin + Tamoxifen in Premenopausal…
NCT00309478 · Austrian Breast & Colorectal Cancer Study Group, Other · Completed
Key facts
| NCT number | NCT00309478 |
|---|---|
| Title | Randomized Study Comparing CMF and Goserelin + Tamoxifen in Premenopausal Receptor-positive Patients |
| Official title | A Randomized Phase III Study Comparing Cyclophosphamide + Methotrexate + Fluorouracil vs. Goserelin + Tamoxifen in Premenopausal, Hormone Receptor-positive, Lymph Node-positive or -Negative Patients |
| Lead sponsor | Austrian Breast & Colorectal Cancer Study Group, Other |
| Collaborators | AstraZeneca Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Early-stage Breast Cancer |
| Intervention type | Drug |
| Interventions | Cyclophosphamide, Methotrexate, Fluorouracil implant, Goserelin, Tamoxifen |
| Enrollment | 1,099 |
| Start date | Dec 1, 1990 |
| Primary completion | Jun 1, 2004 |
| Completion | Jun 1, 2004 |
| First posted | Apr 3, 2006 |
| Last update posted | Jun 29, 2023 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: